Clinical Trials Browser

Phase 2 × Has results × Hizentra × Clear all

NCT02100969 2021-06-02

Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis

Phase 2 Completed

23 enrolled 18 charts

Myasthenia Gravis